Abstract
Poor-quality artemisinin-containing antimalarials (ACAs), including falsified and substandard formulations, pose serious health concerns in malaria endemic countries. They can harm patients, contribute to the rise in drug resistance and increase the public's mistrust of health systems. Systematic assessment of drug quality is needed to gain knowledge on the prevalence of the problem, to provide Ministries of Health with evidence on which local regulators can take action. We used three sampling approaches to purchase 677 ACAs from 278 outlets on Bioko Island, Equatorial Guinea as follows: convenience survey using mystery client (n=16 outlets, 31 samples), full island-wide survey using mystery client (n=174 outlets, 368 samples) and randomised survey using an overt sampling approach (n=88 outlets, 278 samples). The stated active pharmaceutical ingredients (SAPIs) were assessed using high-performance liquid chromatography and confirmed by mass spectrometry at three independent laboratories. Content analysis showed 91.0% of ACAs were of acceptable quality, 1.6% were substandard and 7.4% falsified. No degraded medicines were detected. The prevalence of medicines without the SAPIs was higher for ACAs purchased in the convenience surv...Continue Reading
References
Oct 20, 2007·BMJ : British Medical Journal·Erik von ElmUNKNOWN STROBE Initiative
Mar 27, 2009·PLoS Medicine·Paul N NewtonNicholas J White
Dec 14, 2011·Malaria Journal·Paul N NewtonFacundo M Fernández
May 29, 2012·The Lancet Infectious Diseases·Gaurvika M L NayyarJames Herrington
Jun 7, 2012·Drug Discovery Today·Walter Rangel CamposHeinrich C Hoppe
Sep 25, 2012·Lancet·Carlos J ChaccourJose L Del Pozo
Nov 14, 2012·Parasites & Vectors·Hans J OvergaardMichel A Slotman
Jan 11, 2013·Chemical Reviews·María Eugenia MongeFacundo M Fernández
Feb 1, 2013·Malaria Research and Treatment·Zahra ZamaniMohammad Arjmand
Feb 25, 2014·Lancet·Abdisalan M NoorRobert W Snow
Apr 10, 2014·Malaria Journal·Patricia TaberneroPaul N Newton
Jul 31, 2014·The New England Journal of Medicine·Elizabeth A AshleyUNKNOWN Tracking Resistance to Artemisinin Collaboration (TRAC)
Oct 12, 2014·The Lancet Global Health·Paul N NewtonFacundo M Fernández
Feb 17, 2015·Expert Review of Anti-infective Therapy·Carlos ChaccourJose Luis Del Pozo
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Shunmay YeungHarparkash Kaur
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene· Act Consortium Drug Quality Project Team And The Impact Study Team
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Gaurvika M L NayyarJames E Herrington
May 29, 2015·PloS One·Harparkash KaurObinna Onwujekwe
Mar 10, 2016·The American Journal of Tropical Medicine and Hygiene·Zoe HallHarparkash Kaur
May 18, 2016·Expert Review of Anti-infective Therapy·Paul N NewtonPhilippe J Guerin
May 19, 2016·Expert Opinion on Pharmacotherapy·Nicholas J White
Feb 22, 2017·The American Journal of Tropical Medicine and Hygiene·Benjamin K WilsonDavid Bell
May 17, 2017·Malaria Journal·Mirza LalaniHarparkash Kaur
Citations
Aug 30, 2020·BMJ Global Health·Dominic McManus, Bernard David Naughton
Dec 12, 2018·Malaria Journal·Jiang-Tao ChenMin Lin
Dec 4, 2020·PloS One·Cathrin HaukLutz Heide